N. Tobarran & B.K. Wills. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
765
770
.
Eric J. Lavonas, Peter D. Akpunonu, Ann M. Arens, Kavita M. Babu, Dazhe Cao, Robert S. Hoffman, Christopher O. Hoyte, Maryann E. Mazer-Amirshahi, Andrew Stolbach, Maude St-Onge, Trevonne M. Thompson, George Sam Wang, Amber V. Hoover & Ian R. Drennan. (2023) 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation.
Crossref
Shaokui Wei, Manette T. Niu & Graça M. Dores. (2021) Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019. Drugs - Real World Outcomes 8:2, pages 253-262.
Crossref
Jiri Patocka, Eugenie Nepovimova, Wenda Wu & Kamil Kuca. (2020) Digoxin: Pharmacology and toxicology—A review. Environmental Toxicology and Pharmacology 79, pages 103400.
Crossref
J. Peter R. Pelletier & Faisal Mukhtar. 2020. Immunologic Concepts in Transfusion Medicine. Immunologic Concepts in Transfusion Medicine
251
348
.
Hooman Arbabian, Hwee Min Lee & Andis Graudins. (2018) Elderly patients with suspected chronic digoxin toxicity: A comparison of clinical characteristics of patients receiving and not receiving digoxin‐Fab. Emergency Medicine Australasia 30:2, pages 242-248.
Crossref
Stephan Glund & Monika Kroez. 2017. Protein Therapeutics. Protein Therapeutics
621
643
.
Bernd Moritz & Jan Olaf Stracke. (2017) Assessment of disulfide and hinge modifications in monoclonal antibodies. ELECTROPHORESIS 38:6, pages 769-785.
Crossref
Bruno Mégarbane. 2017. Critical Care Toxicology. Critical Care Toxicology
1
10
.
Bruno Mégarbane. 2017. Critical Care Toxicology. Critical Care Toxicology
807
819
.
Bruno Mégarbane. 2017. Critical Care Toxicology. Critical Care Toxicology
2715
2724
.
Bruno Mégarbane. 2016. Critical Care Toxicology. Critical Care Toxicology
1
14
.
Bruno Mégarbane. 2016. Critical Care Toxicology. Critical Care Toxicology
1
10
.
M.P. Emswiler & B.K. Wills. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
151
154
.
Saurabh Rajpal, Jagan Beedupalli & Pratap Reddy. (2012) Recrudescent Digoxin Toxicity Treated with Plasma Exchange: A Case Report and Review of Literature. Cardiovascular Toxicology 12:4, pages 363-368.
Crossref
Manish Gupta, Omender Singh, Alka Bhasin & Archana Chaturvedi. (2012) Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report. Indian Journal of Critical Care Medicine 16:4, pages 231-233.
Crossref
Salmaan Kanji & Robert D. MacLean. (2012) Cardiac Glycoside Toxicity. Critical Care Clinics 28:4, pages 527-535.
Crossref
Jeanna M. MarraffaVictor CohenMary Ann Howland. (2012) Antidotes for toxicological emergencies: A practical review. American Journal of Health-System Pharmacy 69:3, pages 199-212.
Crossref
M P Timsina & D S Hewick. (1991) The plasma kinetics of digoxin-specific Fab fragments and digoxin in the rabbit. Journal of Pharmacy and Pharmacology 43:11, pages 807-810.
Crossref
F. Eyer, W. Steimer, C. Muller & T. Zilker. (2009) Free and Total Digoxin in Serum During Treatment of Acute Digoxin Poisoning With Fab Fragments: Case Study. American Journal of Critical Care 19:4, pages 391-387.
Crossref
Pascal Bilbault, Rachid Oubaassine, Hassene Rahmani, Thomas Lavaux, Vincent Castelain, Philippe Sauder & Francis Schneider. (2009) Emergency step-by-step specific immunotherapy in severe digoxin poisoning: an observational cohort study. European Journal of Emergency Medicine 16:3, pages 145-149.
Crossref
Frédéric Lapostolle, Stephen W. Borron, Carine Verdier, Fabrice Arnaud, James Couvreur, Bruno Mégarbane, Frédéric Baud & Frédéric Adnet. (2008) Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure. Intensive Care Medicine 34:8, pages 1448-1453.
Crossref
FRÉDÉRIC LAPOSTOLLE & STEPHEN W. BORRON. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
949
962
.
David P. BettenRais B. Vohra, Matthew D. Cook, Michael J. Matteucci & Richard F. Clark. (2016) Antidote Use in the Critically Ill Poisoned Patient. Journal of Intensive Care Medicine 21:5, pages 255-277.
Crossref
Michael Wahl. 2005. Encyclopedia of Toxicology. Encyclopedia of Toxicology
45
47
.
D Nicholas Bateman. (2004) Digoxin-Specific Antibody Fragments. Toxicological Reviews 23:3, pages 135-143.
Crossref
Robert J Flanagan & Alison L Jones. (2004) Fab Antibody Fragments. Drug Safety 27:14, pages 1115-1133.
Crossref
. 2004. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology. Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology
311
326
.
Alison Jones & Robert Flanagan. 2001. Antidotes. Antidotes
96
123
.
Stewart Sell. 2001. Immunology, Immunopathology, and Immunity. Immunology, Immunopathology, and Immunity
240
275
.
Vicente L. González Andrés. (2000) Revisión sistemática sobre la efectividad e indicaciones de los anticuerpos antidigoxina en la intoxicación digitálica. Revista Española de Cardiología 53:1, pages 49-58.
Crossref
Wilhelm Behringer, Fritz Sterz, Hans Domanovits, Waltraud Schoerkhuber, Michael Holzer, Manuela Foedinger & Anton N Laggner. (1998) Percutaneous cardiopulmonary bypass for therapy resistant cardiac arrest from digoxin overdose. Resuscitation 37:1, pages 47-50.
Crossref
Claudio Ronco & Rinaldo BellomoCharles A. Read. 1998. Critical Care Nephrology. Critical Care Nephrology
897
905
.
Chantal Bismuth, Stephen W Borron, Frédéric J Baud, Pierre Taboulet & Jean-Michel Scherrmann. (2016) Immunotoxicotherapy: Successes, disappointments and hopes. Human & Experimental Toxicology 16:10, pages 602-608.
Crossref
Frédéric J. Baud, Stephen W. Borron, Jean-Michel Scherrmann & Chantal Bismuth. 1997. Applied Toxicology: Approaches Through Basic Science. Applied Toxicology: Approaches Through Basic Science
271
287
.
Alan Woolf. (2012) Digitalis Intoxication. Clinical Immunotherapeutics 4:4, pages 312-330.
Crossref
George M. Bosse & Thomas M. Pope. (1994) Recurrent digoxin overdose and treatment with digoxin-specific Fab antibody fragments. The Journal of Emergency Medicine 12:2, pages 179-185.
Crossref
V. Kurowski, H. Iven & H. Djonlagic. (1992) Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies. Intensive Care Medicine 18:7, pages 439-442.
Crossref
Alan D. Woolf, Thomas Wenger, Thomas W. Smith & Frederick H. LovejoyJr.Jr.. (1992) The Use of Digoxin-Specific Fab Fragments for Severe Digitalis Intoxication in Children. New England Journal of Medicine 326:26, pages 1739-1744.
Crossref
C. Bismuth & F.-J. Baud. 1992. Care of the Critically Ill Patient. Care of the Critically Ill Patient
1057
1089
.
W. G. Wood, P. Färber & V. Kurowski. (1990) A case of divergent digitoxin values under treatment of a patient with acute digitoxin overdose with digitalis antibody fragments. Klinische Wochenschrift 68:6, pages 324-327.
Crossref
M. Urtizberea, A. Sabouraud, N. Terrien & J.M. Scherrmann. (1989) Immunotoxicothérapie : stratégie dans la préparation et l'administration des anticorps spécifiques. Immuno-analyse & Biologie Spécialisée 4:5, pages 17-25.
Crossref
Gregory L. Kearns, M. Michele Moss, Bruce D. Clayton & Debra D. Hewett. (1989) Pharmacokinetics and Efficacy of Digoxin Specific Fab Fragments in a Child Following Massive Digoxin Overdose. The Journal of Clinical Pharmacology 29:10, pages 901-908.
Crossref
E. Erdmann, W. Mair, M. Knedel & W. Schaumann. (1989) Digitalis intoxication and treatment with digoxin antibody fragments in renal failure. Klinische Wochenschrift 67:1, pages 16-19.
Crossref
William Clarke & Edward A. Ramoska. (1988) Acute digoxin overdose: Use of digoxin-specific antibody fragments. The American Journal of Emergency Medicine 6:5, pages 465-470.
Crossref
Douglas A Propp, Tess Hogan & Jim Mattimore. (1988) Nausea, dyspnea, and heart block in an 86-year-old patient with congestive heart failure. Annals of Emergency Medicine 17:3, pages 261-267.
Crossref
Hillel Savin, Leon Marcus, Shlomo Margel, Michal Ofarim & Mordchai Ravid. (1987) Treatment of adverse digitalis effects by hemoperfusion through columns with antidigoxin antibodies bound to agarose polyacrolein microsphere beads. American Heart Journal 113:5, pages 1078-1084.
Crossref
V G Tirlapur. (1986) Intermittent hypoxia in patients with unexplained polycythaemia.. BMJ 293:6555, pages 1172-1173.
Crossref
I Gibb & A Parnham. (1986) A star treatment for digoxin overdose?. BMJ 293:6555, pages 1171-1172.
Crossref
Per Kulling & Hans Persson. (2012) Role of the Intensive Care Unit in the Management of the Poisoned Patient. Medical Toxicology 1:5, pages 375-386.
Crossref
A T Proudfoot. (1986) A star treatment for digoxin overdose?. BMJ 293:6548, pages 642-643.
Crossref